ORANGE, CA, August 28, 2012 (Press-News.org) On Target Voice and Data, Inc., an electrical and telecommunications contractor (www.teamontarget.com), announced today that it has completed its acquisition of the business assets of Fusion IP, Irvine, California, an IT solutions provider serving global Fortune 1000 customers.
The Fusion IP acquisition allows for the expansion of On Target's capabilities by adding multiple network solutions to their already impressive diverse portfolio of product and services. These solutions include monitoring and managing customer networks, technical support, cloud computing, data center network security, storage, unified communications, virtualization, VoIP (Voice over IP) and video conferencing. As a result, On Target is now able to offer their customers a complete suite of networking solutions to choose from depending on their application needs.
In addition, On Target has certified specialists with extensive experience in designing and engineering a full range of cloud computing environments from small pods to multi-chassis solutions. On Target's CCIE(R) certified data center professionals bring a wealth of knowledge and insight that can assist with the set up of their customer's on-demand (OD) computing.
On Target is also in the position to help their customers get ahead of their competition with "just-in-time elastic agility" computing concerning their private, public, or hybrid cloud platforms. The emphasis on elasticity, will provide them with a return-on-investment (ROI), enabling them to maximize the benefits from the hardware they purchased and deployed.
"By combining these two businesses into one, we share a vision for future significant growth through the addition of complimentary products, technologies and people. Together, it will enable us to create and deliver new robust technology platforms and operating systems that will best benefit our customers in all the vertical markets that we serve," states Stef Rohr, previously Fusion IP's CEO and now vice president of sales for On Target.
Aaron Egdahl, On Target's CEO, said, "We welcome Fusion IP to the On Target team and I am very excited to work with the Fusion IP team to capitalize on the numerous opportunities ahead for our networking business and company. We are committed to a flawless integration of Fusion IP and look forward to delivering these additional value-added products and solutions to our customers while maintaining the same great service they've come to expect from On Target."
For more information on the Fusion IP acquisition, products and services, please contact On Target at 886-688-3462 or info@teamontarget.com.
About On Target
On Target Voice and Data, Inc. and On Target Electric, Inc., based in Orange, California, are industry leaders in network, electrical construction and energy solutions. As a full-service electrical and telecommunications company, On Target represents leading-edge manufacturers such as Cisco, AMX SchoolView, Microsoft and other system solutions providers. On Target is committed to providing its customers with the absolute highest standards in design, installation and service.
On Target Voice and Data Acquires IT Solutions Provider Fusion IP
On Target Voice and Data, Inc., an electrical and telecommunications contractor (www.teamontarget.com), announced today that it has completed its acquisition of the business assets of Fusion IP, Irvine, California, an IT solutions provider serving global Fortune 1000 customers.
2012-08-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Electronic cigarettes do not damage the heart
2012-08-27
Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, with several millions of people already using them worldwide.
Electronic cigarettes simulate the effect of smoking by producing an inhaled vapor. The device consists of a battery, a cartridge containing liquid and a heating element which gets warm and evaporates the liquid. Laboratory analyses of the liquids show that they are less toxic than regular ...
Non-smokers benefit most from smoking ban
2012-08-27
After the smoking ban was introduced in Bremen, Germany, the rate of ST-elevation myocardial infarction (STEMI) diminished by 26% in non-smokers but remained almost constant in active smokers, according to research presented today at the ESC Congress 2012. The results were presented by Dr Johannes Schmucker from Germany.
Many European countries have passed anti-smoking legislation which bans smoking from restaurants, bars and public buildings. After implementation of such a smoking ban on 1 January 2008 in the metropolitan area of Bremen in northwest Germany (800,000 ...
Adolescent smokers have artery damage
2012-08-27
Adolescent smokers have thicker artery walls indicative of early development of atherosclerosis, according to research presented today at the ESC Congress. The findings from the Sapaldia Youth Study were presented by Dr Julia Dratva from Switzerland.
Early exposure to tobacco smoke is associated with various adverse health outcomes in children and adolescents, including low birth weight and impaired lung growth and function. Tobacco smoke is considered highly atherogenic in adults, but little is known about the impact of tobacco smoke exposure on cardiovascular health ...
Heart separation device improves 3 year outcomes in heart failure patients
2012-08-27
Munich, Germany – A novel non-invasive device which separates healthy and damaged heart muscle and restores ventricle function improves 3 year outcomes in patients with ischemic heart failure, according to research presented at the ESC Congress 2012. The findings were presented by Professor William T. Abraham at an ESC press conference on 25 August and by Dr Marco Costa at an ESC Congress scientific session on 27 August.
Heart failure is a common, debilitating, and potentially deadly condition in which the heart is unable to supply sufficient blood flow to meet the needs ...
Promising new drug target discovered for treatment and prevention of heart failure
2012-08-27
Munich, Germany – A promising new drug target for the treatment and prevention of heart failure has been discovered by researchers at Mount Sinai School of Medicine in New York, NY, US. The study was presented at the ESC Congress 2012 by principal investigator Professor Roger J. Hajjar, MD.
According to the US Centers for Disease Control and Prevention, about 5.8 million Americans suffer from heart failure and 670,000 new cases are diagnosed each year. One in five people with heart failure die within one year of diagnosis. Heart failure is most often treated with aggressive ...
Novel anti-platelet therapy reduces risk of cardiac events in patients with history of heart attack
2012-08-27
According to new research from Brigham and Women's Hospital (BWH), adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the long-term risk of recurrent cardiovascular events beyond one year in patients with a history of a prior heart attack. Researchers also identify a low-bleeding risk group among whom the clinical benefit of vorapaxar was particularly favorable. This research is presented at the European Society of Cardiology Congress 2012 and published simultaneously in the Lancet.
For more than a million Americans ...
The PURE study
2012-08-27
Munich, Germany – Healthy foods such as fruits and vegetables, proteins and non-saturated fats are consumed more often by the wealthy while poorer people consume more carbohydrates, concludes a new study involving people from 17 countries.
Results from the Prospective Urban Rural Epidemiology (PURE) study were reported here today by Professor Salim Yusuf of the Population Health Research Institute, McMaster University and Hamilton Health Sciences, in Hamilton, Canada and principal investigator of the study. The study,
involving 154,000 individuals from 628 communities, ...
The DeFACTO study
2012-08-27
Munich, Germany – Data presented today from the prospective Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO) study show that, when compared to standard coronary angiography (CT), the non-invasive assessment of fractional flow reserve by computed tomography (FFRct) provides a more accurate determination of which lesions require invasive evaluation.(1)
The results of the study were presented by Dr James K. Min, director of Cardiac Imaging Research and co-director of Cardiac Imaging at the Department of Medicine, Imaging and ...
Median follow-up results from the ALTITUDE study, stopped prematurely in December 2011
2012-08-27
Munich, Germany – Preliminary results from the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) do not support administration of aliskiren on top of standard therapy with renin-angiotensin-aldosterone system (RAAS) blockade in type 2 diabetics at high risk of cardiovascular and renal events, according to Professor Hans-Henrik Parving from Rigshospitalet, University of Copenhagen, Denmark. Presenting results from the study today, he said the treatment "may even be harmful".
The ALTITUDE trial was stopped prematurely in December 2011 on recommendation ...
The TRILOGY ACS study
2012-08-27
Munich, Germany – The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference between prasugrel and clopidogrel in the prevention of death, myocardial infarction or stroke.
The findings, from the phase III Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) study, were presented today at a Hot Line session of ESC Congress 2012 in Munich.
TRILOGY ACS was double-blind, randomised trial ...
LAST 30 PRESS RELEASES:
CRISPR primes goldenberry for fruit bowl fame
Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment
Fat tissue around the heart may contribute to greater heart injury after a heart attack
Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America
Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression
Cartilaginous cells regulate growth and blood vessel formation in bones
Plant hormone allows lifelong control of proteins in living animal for first time
Swedish freshwater bacteria give new insights into bacterial evolution
Global measures consistently underestimate food insecurity; one in five who suffer from hunger may go uncounted
Hidden patterns of isolation and segregation found in all American cities
FDA drug trials exclude a widening slice of Americans
Sea reptile’s tooth shows that mosasaurs could live in freshwater
Pure bred: New stem cell medium only has canine components
Largest study of its kind highlights benefits – and risks – of plant-based diets in children
Synergistic effects of single-crystal HfB2 nanorods: Simultaneous enhancement of mechanical properties and ablation resistance
Mysterious X-ray variability of the strongly magnetized neutron star NGC 7793 P13
The key to increasing patients’ advance care medical planning may be automatic patient outreach
Palaeontology: Ancient tooth suggests ocean predator could hunt in rivers
Polar bears may be adapting to survive warmer climates, says study
Canadian wildfire smoke worsened pediatric asthma in US Northeast: UVM study
New UBCO research challenges traditional teen suicide prevention models
Diversity language in US medical research agency grants declined 25% since 2024
Concern over growing use of AI chatbots to stave off loneliness
Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows
The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
Blood test reveals prognosis after cardiac arrest
UBCO study finds microdosing can temporarily improve mood, creativity
An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study
[Press-News.org] On Target Voice and Data Acquires IT Solutions Provider Fusion IPOn Target Voice and Data, Inc., an electrical and telecommunications contractor (www.teamontarget.com), announced today that it has completed its acquisition of the business assets of Fusion IP, Irvine, California, an IT solutions provider serving global Fortune 1000 customers.